RecruitingNCT06033274

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry

Sponsor

Montefiore Medical Center

Enrollment

800 participants

Start Date

Oct 5, 2023

Study Type

OBSERVATIONAL

Conditions

Tricuspid Regurgitation

Summary

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Patients undergoing Transcatheter Tricuspid Valve Replacement
Native Tricuspid Valve disease
Orthotopic Tricuspid Valve Implantation

Exclusion Criteria1

Age under 18 years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscatheter Tricuspid Valve Replacement

All patients undergoing Transcatheter Tricuspid Valve Replacement for native tricuspid valve disease

Locations(21)

Arizona Heart Hospital (Biltmore Cardiology)

Phoenix, Arizona, United States

Columbia University Irving Medical Center

New York, New York, United States

Montefiore Medical Center

The Bronx, New York, United States

Cleveland Clinic

Cleveland, Ohio, United States

Oregon Health & Science University

Portland, Oregon, United States

St. Paul's Hospital

Vancouver, British Columbia, Canada

St Michael's Hospital, University of Toronto

Toronto, Ontario, Canada

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada

Québec, Quebec, Canada

Rigshospitalet, Copenhagen University Hospital

Copenhagen, Denmark

Chu De Bordeaux - Haut-Lévêque Hospital

Bordeaux, Pessac, France

Centre Hospitalier Universitaire de Lille

Lille, France

Clinique Pasteur Toulouse

Toulouse, France

Heart and Diabetes Centre, North Rhine-Westphalia (NRW), Ruhr-University

Bad Oeynhausen, Germany

Heart Center Cologne, University of Cologne

Cologne, Germany

Cardiovascular Center (CVC) Frankfurt, Division of Cardiology

Frankfurt, Germany

University Heart and Vascular Center, Department of Cardiology

Hamburg, Germany

University Heart Center, Schleswig-Holstein University

Lübeck, Germany

Medical Clinic and Polyclinic, University Hospital of Munich (LMU Klinikum)

Munich, Germany

San Raffaele University Hospital

Milan, Italy

Centro Cardiologico Monzino IRCCS

Milan, Italy

University Hospital Alvaro Cunqueiro (CHUVI)

Vigo, Pontevedra, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06033274

Related Trials

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

NCT0409714579 locations

TriClip Japan Post-Approval Study

NCT075096581 location

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

NCT0584828411 locations

Berlin Registry of Right Heart Interventions

NCT045701631 location

Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

NCT074641061 location